Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

This study is ongoing, but not recruiting participants.

Study NCT00708084. Last updated on October 8, 2008. Information provided by Crucell Holland BV

Please refer to this study by its ClinicalTrials.gov identifier: NCT00708084

Locations


Philippines
	Research Institute for Tropical Medicine
	Alabang, Muntinlupa, Metro Manila, Philippines

Sponsors and Collaborators

Crucell Holland BV

Investigators


Principal Investigator:	Beatriz P. Quiambao, MD	Research Institute for Tropical Medicine, Alabang, Muntinlupa, Metro Manila, Philippines